NCT03377426View on ClinicalTrials.gov

LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Urinary Tract Infection (cUTI)

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 19, 2018

Primary Completion Date

October 28, 2019

Study Completion Date

October 28, 2019

Conditions
Complicated Urinary Tract Infections
Interventions
DRUG

LYS228

LYS228 IV infusion

DRUG

Standard of care therapy

IV infusion of standard of care antibiotics

Trial Locations (5)

5000

Novartis Investigative Site, Odense

48202

Novartis Investigative Site, Detroit

98195

Novartis Investigative Site, Seattle

07102

Novartis Investigative Site, Newark

115 27

Novartis Investigative Site, Athens

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY